Stockscreener 앱 받기
64.63
1.68%
1.07
시간 외 거래:
64.63
전일 마감가:
$63.56
열려 있는:
$63.83
하루 거래량:
637.97K
Relative Volume:
0.84
시가총액:
$3.53B
수익:
$1.39B
순이익/손실:
$-242.49M
주가수익비율:
-14.44
EPS:
-4.4759
순현금흐름:
$173.29M
1주 성능:
+2.10%
1개월 성능:
-8.46%
6개월 성능:
+27.70%
1년 성능:
+65.59%
1일 변동 폭
$63.69
$65.21
1주일 범위
$60.35
$65.21
52주 변동 폭
$32.48
$71.92
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
64.63 | 3.48B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
102.38 | 178.41B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
329.40 | 125.84B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.06 | 111.25B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.00 | 93.26B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.26 | 46.17B | 6.07B | 1.06B | 1.34B | 1.8063 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
(LIVN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Aug Macro: Does LivaNova PLC stock benefit from AI growth2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Tudor Investment Corp ET AL Acquires Shares of 33,332 LivaNova PLC $LIVN - marketbeat.com
How FDA Approval of Aura6000 Sleep Apnea Therapy Will Impact LivaNova (LIVN) Investors - Sahm
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value - Benzinga
Should FDA Approval of aura6000 Sleep Apnea Therapy Require Action From LivaNova (LIVN) Investors? - Yahoo Finance
LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea - Insider Monkey
LivaNova Broadens OSA Treatment Options With FDA Clearance for aura6000 System - Bitget
LivaNova Expands OSA Care With FDA-Approved aura6000 System - Yahoo Finance
LivaNova to Announce First-Quarter 2026 Results - Business Wire
LivaNova PLC stock faces analyst scrutiny amid mixed ratings and modest growth outlook in medical de - AD HOC NEWS
LivaNova gains FDA premarket approval for Aura6000 for sleep apnea - msn.com
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
FDA Approves Hypoglossal Nerve Stimulation Device for OSA - Medical Dialogues
FDA Approves LivaNova’s aura6000 Neurostimulator for OSA - sleepreviewmag.com
LivaNova aura6000 Obstructive Sleep Apnea treatment granted FDA premarket approval - Med-Tech Insights
LivaNova eyes 2027 launch of neural sleep apnoea therapy after FDA approval - Medical Device Network
LivaNova wins FDA approval for sleep apnea nerve device By Investing.com - in.investing.com
How (LIVN) Movements Inform Risk Allocation Models - Stock Traders Daily
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - stocktitan.net
LivaNova granted premarket approval for aura6000 System by FDA - TipRanks
LivaNova wins FDA Approval for sleep apnea treatment device - Medical Economics
LivaNova (LIVN) Receives FDA Approval for Aura6000 Sleep Apnea S - GuruFocus
LivaNova Earns FDA Approval for Neurostim for Sleep Apnea - Medical Product Outsourcing
LivaNova wins FDA approval for sleep apnea nerve device - Investing.com
LivaNova gets FDA approval for sleep apnea device without collapse warning - StreetInsider
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea - The Joplin Globe
LivaNova Shares Gain 2% After Strong Q3 Results and Upgraded Full-Year Outlook - MSN
LivaNova PLC announced that its Aura6000 system has received premarket approval from the U.S. Food and Drug Administration (FDA). The device is designed to treat moderate to severe obstructive sleep apnea. - Bitget
Patterns Watch: Is LivaNova PLC being accumulated by smart moneyMarket Performance Report & Momentum Based Trading Signals - baoquankhu1.vn
Short Interest in LivaNova PLC Rises By 18.0% - National Today
Short Interest in LivaNova PLC (NASDAQ:LIVN) Rises By 18.0% - MarketBeat
LIVN PE Ratio & Valuation, Is LIVN Overvalued - Intellectia AI
Algert Global LLC Cuts Stock Position in LivaNova PLC $LIVN - MarketBeat
LivaNova PLC (LIVN) Stock Price Up 4.47% on Mar 16 - GuruFocus
Boone Capital Management LLC Purchases Shares of 167,932 LivaNova PLC $LIVN - MarketBeat
P2 Capital Partners LLC Trims Stock Holdings in LivaNova PLC $LIVN - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Q3 2025 Earnings Call Transcript - msn.com
LivaNova PLC Stock (ISIN: US5356991077) Faces Headwinds Amid Mixed Guidance and Declining Sentiment - AD HOC NEWS
Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN) - Prime Publishers, Inc.
LivaNova PLC Stock (ISIN: US5356991077) Faces Headwinds Amid MedTech Sector Shifts - AD HOC NEWS
Aug Highlights: Is LivaNova PLC subject to activist investor interest2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Trading Systems Reacting to (LIVN) Volatility - Stock Traders Daily
Victory Capital Management Inc. Has $45.57 Million Position in LivaNova PLC $LIVN - marketbeat.com
American Century Companies Inc. Buys 175,570 Shares of LivaNova PLC $LIVN - MarketBeat
LIVN Earnings History & Surprises | EPS & Revenue Results | LIVANOVA PLC (NASDAQ:LIVN) - ChartMill
Sentiment Recap: Is LivaNova PLC being accumulated by smart money2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy - Yahoo Finance
Vanguard Group Inc. Lowers Holdings in LivaNova PLC $LIVN - MarketBeat
Rock Point Advisors LLC Makes New Investment in LivaNova PLC $LIVN - MarketBeat
LivaNova PLC (LIVN) Stock Analysis: A Promising Upside of 13.72% Amid Robust Revenue Growth - DirectorsTalk Interviews
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Poletti Franco | President, Cardiopulmonary |
Dec 15 '25 |
Option Exercise |
0.00 |
967 |
0 |
9,266 |
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
0.67%
0.54%
자본화:
|
볼륨(24시간):